solifenacin succinate has been researched along with gabapentin in 3 studies
Studies (solifenacin succinate) | Trials (solifenacin succinate) | Recent Studies (post-2010) (solifenacin succinate) | Studies (gabapentin) | Trials (gabapentin) | Recent Studies (post-2010) (gabapentin) |
---|---|---|---|---|---|
522 | 194 | 343 | 4,481 | 767 | 2,069 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (33.33) | 29.6817 |
2010's | 2 (66.67) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Appell, RA; McCrery, RJ; Smith, PP | 1 |
Balingit, JC; Chua, ME; Esmeňa, EB; Morales, ML; See, MC | 1 |
Pannek, J | 1 |
2 review(s) available for solifenacin succinate and gabapentin
Article | Year |
---|---|
The emergence of new drugs for overactive bladder.
Topics: Acetylcholine; Amines; Animals; Anticonvulsants; Benzhydryl Compounds; Cresols; Cyclohexanecarboxylic Acids; Drug Evaluation, Preclinical; Gabapentin; gamma-Aminobutyric Acid; Humans; Mandelic Acids; Muscarinic Antagonists; Muscle, Smooth; Phenylpropanolamine; Product Surveillance, Postmarketing; Quinuclidines; Randomized Controlled Trials as Topic; Receptor, Muscarinic M3; Solifenacin Succinate; Tetrahydroisoquinolines; Tolterodine Tartrate; Urinary Bladder; Urinary Incontinence | 2006 |
[Overactive bladder-which treatment when?]
Topics: Behavior Therapy; Botulinum Toxins, Type A; Diagnosis, Differential; Electric Stimulation Therapy; Female; Gabapentin; Humans; Injections, Intramuscular; Lumbosacral Plexus; Male; Muscarinic Antagonists; Patient Preference; Physical Therapy Modalities; Solifenacin Succinate; Tadalafil; Urinary Bladder; Urinary Bladder, Overactive | 2017 |
1 trial(s) available for solifenacin succinate and gabapentin
Article | Year |
---|---|
Efficacy and Safety of Gabapentin in Comparison to Solifenacin Succinate in Adult Overactive Bladder Treatment.
Topics: Adolescent; Adult; Aged; Amines; Cyclohexanecarboxylic Acids; Double-Blind Method; Drug Administration Schedule; Female; Gabapentin; gamma-Aminobutyric Acid; Humans; Male; Middle Aged; Muscarinic Antagonists; Prospective Studies; Quality of Life; Solifenacin Succinate; Treatment Outcome; Urinary Bladder, Overactive; Urological Agents; Young Adult | 2018 |